Oral Cyclophosphamide Confounds the Relationship between CYP2C19 and CYP2B6 Pharmacogenetics and Cyclophosphamide-induced premature Ovarian Failure in Lupus Nephritis Patients
Advances in Pharmacology and Pharmacy · 2013
DOI: 10.13189/app.2013.010101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Pharmacology and Pharmacy, 2013. Verfasst von Nuala Helsby und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Helsby, N., Goldthorpe, M., Gow, P., & Zoysa, J. D. (2013). Oral Cyclophosphamide Confounds the Relationship between CYP2C19 and CYP2B6 Pharmacogenetics and Cyclophosphamide-induced premature Ovarian Failure in Lupus Nephritis Patients. Advances in Pharmacology and Pharmacy. https://doi.org/10.13189/app.2013.010101
Vancouver
Helsby N, Goldthorpe M, Gow P, Zoysa JD. Oral Cyclophosphamide Confounds the Relationship between CYP2C19 and CYP2B6 Pharmacogenetics and Cyclophosphamide-induced premature Ovarian Failure in Lupus Nephritis Patients. Advances in Pharmacology and Pharmacy. 2013. doi:10.13189/app.2013.010101
BibTeX
@article{Helsby2013,
author = {Helsby, Nuala and Goldthorpe, Michael and Gow, Peter and Zoysa, Janak de},
title = {Oral Cyclophosphamide Confounds the Relationship between CYP2C19 and CYP2B6 Pharmacogenetics and Cyclophosphamide-induced premature Ovarian Failure in Lupus Nephritis Patients},
journal = {Advances in Pharmacology and Pharmacy},
year = {2013},
doi = {10.13189/app.2013.010101}
}
EUVIMED